News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
869,823 Results
Type
Article (87963)
Company Profile (825)
Press Release (781018)
Multimedia
Podcasts (195)
Webinars (28)
Section
Business (233261)
Career Advice (4147)
Deals (39878)
Drug Delivery (150)
Drug Development (91417)
Employer Resources (205)
FDA (18387)
Job Trends (17426)
News (397913)
Policy (39969)
Tag
Academia (3010)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (145)
Alliances (56981)
ALS (180)
Alzheimer's disease (1788)
Antibody-drug conjugate (ADC) (346)
Approvals (18560)
Artificial intelligence (621)
Autoimmune disease (156)
Automation (35)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (200)
Biotechnology (490)
Bladder cancer (162)
Brain cancer (65)
Breast cancer (656)
Cancer (4996)
Cardiovascular disease (439)
Career advice (3570)
Career pathing (41)
CAR-T (302)
CDC (59)
Celiac Disease (1)
Cell therapy (822)
Cervical cancer (37)
Clinical research (76973)
Collaboration (1788)
Company closure (5)
Compensation (1147)
Complete response letters (70)
COVID-19 (2991)
CRISPR (98)
C-suite (844)
Cystic fibrosis (154)
Data (6207)
Decentralized trials (2)
Denatured (71)
Depression (150)
Diabetes (530)
Diagnostics (7218)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (299)
Drug pricing (222)
Drug shortages (36)
Duchenne muscular dystrophy (239)
Earnings (100092)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (135032)
Executive appointments (1031)
FDA (21531)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1543)
Gene editing (214)
Generative AI (63)
Gene therapy (666)
GLP-1 (1118)
Government (5438)
Grass and pollen (8)
Guidances (385)
Healthcare (20943)
HIV (60)
Huntington's disease (48)
IgA nephropathy (86)
Immunology and inflammation (289)
Immuno-oncology (57)
Indications (88)
Infectious disease (3277)
Inflammatory bowel disease (205)
Inflation Reduction Act (17)
Influenza (119)
Intellectual property (243)
Interviews (816)
IPO (17954)
IRA (60)
Job creations (5199)
Job search strategy (2866)
JPM (66)
Kidney cancer (17)
Labor market (92)
Layoffs (659)
Leadership (40)
Legal (10160)
Liver cancer (98)
Longevity (14)
Lung cancer (676)
Lymphoma (375)
Machine learning (45)
Management (66)
Manufacturing (836)
MASH (172)
Medical device (15016)
Medtech (15064)
Mergers & acquisitions (22975)
Metabolic disorders (1385)
Multiple sclerosis (161)
NASH (23)
Neurodegenerative disease (352)
Neuropsychiatric disorders (96)
Neuroscience (3097)
Neurotech (1)
NextGen: Class of 2026 (7707)
Non-profit (5110)
Now hiring (64)
Obesity (670)
Opinion (335)
Ovarian cancer (166)
Pain (204)
Pancreatic cancer (230)
Parkinson's disease (297)
Partnered (39)
Patents (498)
Patient recruitment (470)
Peanut (60)
People (66871)
Pharmaceutical (145)
Pharmacy benefit managers (32)
Phase I (23788)
Phase II (33399)
Phase III (25172)
Pipeline (4887)
Policy (334)
Postmarket research (3554)
Preclinical (10690)
Press Release (72)
Prostate cancer (242)
Psychedelics (53)
Radiopharmaceuticals (298)
Rare diseases (885)
Real estate (7439)
Recruiting (80)
Regulatory (28959)
Reports (67)
Research institute (2722)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (158)
Series A (256)
Series B (195)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (112)
Tariffs (99)
The Weekly (122)
Vaccines (1141)
Venture capital (94)
Weight loss (461)
Women's health (85)
Worklife (21)
Date
Today (21)
Last 7 days (358)
Last 30 days (2222)
Last 365 days (32910)
2026 (2135)
2025 (33228)
2024 (38141)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (88)
Alaska (7)
Arizona (340)
Arkansas (14)
Asia (51532)
Australia (9045)
California (11458)
Canada (3293)
China (1154)
Colorado (485)
Connecticut (497)
Delaware (343)
Europe (118389)
Florida (1673)
Georgia (369)
Hawaii (4)
Idaho (68)
Illinois (956)
India (66)
Indiana (540)
Iowa (24)
Japan (420)
Kansas (133)
Kentucky (42)
Louisiana (29)
Maine (83)
Maryland (1449)
Massachusetts (8443)
Michigan (354)
Minnesota (662)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (85)
New Jersey (3082)
New Mexico (33)
New York (3031)
North Carolina (1602)
North Dakota (10)
Northern California (5468)
Ohio (350)
Oklahoma (22)
Oregon (54)
Pennsylvania (2292)
Puerto Rico (21)
Rhode Island (50)
South America (1661)
South Carolina (64)
South Dakota (1)
Southern California (4424)
Tennessee (175)
Texas (1807)
United States (41354)
Utah (343)
Vermont (1)
Virginia (288)
Washington D.C. (87)
Washington State (960)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
There are 869,823 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE-2 Phase 3 Clinical Trial in ATTRv-PN
January 28, 2026
·
6 min read
Press Releases
Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026
January 28, 2026
·
1 min read
Press Releases
Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide
January 28, 2026
·
6 min read
Press Releases
Science 37 Appoints Kelly Johnston McKee as VP of Strategy & Transformation
January 28, 2026
·
2 min read
Press Releases
ABLi Therapeutics Completes Collaboration Agreement with The Michael J. Fox Foundation to include Risvodetinib in Path to Prevention Platform Trial
January 28, 2026
·
4 min read
Cancer
J&J’s Darzalex Faspro Notches Another Multiple Myeloma Indication, Pushing Into Frontline
Darzalex Faspro, in combination with an anti-cancer triplet, is the first anti-CD38-based regimen for newly diagnosed patients with multiple myeloma, regardless of eligibility for stem cell transplantation.
January 28, 2026
·
2 min read
·
Tristan Manalac
gene therapy
Advanced Therapies Week 2026: ‘Solving for Science’ and Weathering Global Complexity
Phacilitate’s annual event dawns as cell and gene therapies reach a new tipping point: the science has hit new heights just as regulatory and government policies spark momentum and frustration.
January 28, 2026
·
4 min read
·
Heather McKenzie
Press Releases
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
January 28, 2026
·
6 min read
Press Releases
Cytokinetics Announces MYQORZO™ (aficamten) Now Available in the U.S. for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms
January 28, 2026
·
12 min read
Press Releases
Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics
January 28, 2026
·
7 min read
1 of 86,983
Next
